Arati discusses the complexities surrounding the use of proprietary data in AI training, particularly in pharmaceuticals. She emphasizes the need for agreements on compensation for data usage, paralleling the ongoing legal challenges faced by LLMs and image generators. The conversation raises critical questions about fairness and the future of AI development in light of existing intellectual property laws.
